ASX BRIEFS

Andrew Musgrave

Welcome to 'ASX BRIEFS,' the definitive podcast for enthusiasts, investors, and professionals keen on staying ahead of the curve in the Australian Stock Exchange (ASX). Hosted by Andrew Musgrave, 'ASX BRIEFS' delves deep into the heart of Australia's financial markets, bringing you insightful conversations with the minds shaping the future of investing down under. Each episode, join Andrew as he interviews a diverse lineup of fund managers, executives, and industry insiders, offering you a unique blend of expert analysis, strategic insights, and the latest trends affecting the ASX. Whether you're a seasoned investor or just starting out, 'ASX BRIEFS' is your go-to source for comprehensive updates and thought-provoking discussions designed to inform, inspire, and empower your investment journey. Tune in to 'ASX BRIEFS' and take the pulse of Australia's financial markets right at your fingertips.

  1. 4d ago

    VHM LIMITED (ASX:VHM) - Goschen’s Rare Earths Moment

    Send us Fan Mail Rare earths projects don’t usually sound simple, but VHM Limited is pitching Goschen as exactly that: a shallow sand deposit in north-west Victoria with no blasting, no crushing, and mining above the water table. We’re joined by CEO Andrew King to break down why that practical reality matters just as much as the headline numbers when you’re trying to finance and build a critical minerals operation in Australia. We unpack the refreshed definitive feasibility study (DFS), including the pre-tax NPV of about A$807 million, a 33% IRR, and an expected three-year payback from first production. Andrew walks us through the main drivers behind those returns, from low-energy mining through to a pricing structure that links the rare earth concentrate to market outcomes via the Iluka offtake agreement. We also talk about cost confidence, what “market-tested” capex actually means, and how currency moves can shift the picture even when inputs stay steady. A standout theme is resilience. Goschen targets two revenue streams: rare earth concentrate and a heavy mineral concentrate containing zircon and titanium. That second product doesn’t just add upside, it can materially lower effective rare earth operating costs and reduce exposure to rare earth price volatility. We also explore the developing relationship with Mitsui, the role of Export Finance Australia and the US EXIM Bank, and why government support has become almost standard for Western rare earth supply chains. If you care about Australian rare earths, project finance, and how Victoria fits into the global critical minerals race, hit play, subscribe, and share the episode. If you enjoy it, please leave a review and tell us what topic you want us to tackle next.

  2. Nov 12

    NICKEL INDUSTRIES LTD (ASX:NIC) - Nickel Profits In Indonesia

    Send us Fan Mail ASX Investment Opportunity - Nickel Industries Ltd (ASX:NIC) US$125 million plus in quarterly adjusted EBITDA grabs attention, but the real story is what sits underneath the number. We sit down with Justin Werner, Managing Director of Nickel Industries Limited, to unpack how mining performance in Indonesia lifts sales volumes, strengthens per-tonne margins, and delivers a second consecutive strong result from the operations that feed the broader processing strategy. If you follow ASX resources, nickel mining, or critical minerals, this is a grounded look at what actually moves the dial quarter to quarter. From there we shift into the Excelsior Nickel Cobalt (ENC) project and the moment commissioning starts turning into product. Justin walks us through first ore sent via slurry pipeline, first mixed hydroxide precipitate (MHP), then first Class 1 nickel cathode and first cobalt cathode production, including the steps towards LME registration and the practical readiness for first commercial sales. We also touch on the OCBC led project finance facility and what it means for funding flexibility as the ramp up continues. Then reality hits: El Nino conditions and unusually low rainfall create water shortages that limit throughput across the park, even when equipment can be tested at full capacity. We finish with the Sampala nickel project stake swap, what a 1.3 billion valuation implies, and the on-the-ground constraints that matter most next, like haul road buildout and forestry permits. Subscribe, share this with a mate who follows the nickel market, and leave a review with your biggest question about downstream processing and margins.

  3. Nov 8

    EPIMINDER LTD (ASX:EPI) - A New Standard For Epilepsy Monitoring

    Send us Fan Mail ASX Investment Opportunity - Epiminder Ltd (ASX:EPI) Seizure diaries ask people to remember the hardest moments of their lives, then clinicians are expected to make high-stakes treatment calls off that memory. That’s the gap Epiminder Limited wants to close, and we’re joined by CEO Rohan Hoare to explain how continuous long-term EEG monitoring could push epilepsy care towards objective evidence rather than best guesses.  Rohan breaks down what Epiminder actually builds: an implantable EEG device placed under the scalp, paired with a wearable, a companion phone, and a cloud app. We talk about why long-duration brain activity monitoring across months to years can reveal patterns that short clinical snapshots miss, and why that matters for drug-resistant epilepsy. He also shares a striking data point from Australian work used for FDA authorisation, where EEG monitoring informed clinical decision making 88% of the time, a reminder that better data can directly shape better care.  We then dig into execution and timelines: the US DETECT post-market reimbursement trial has enrolled its 100th participant ahead of schedule across 23 centres, including leading institutions like Harvard, Stanford, Yale, UPenn, and Mayo. Rohan outlines the milestones to watch through 2026 and into 2027, the recent FDA clearance expanding the indicated age range to patients aged 12 and older, and how Epiminder’s strong cash position supports four priorities: completing DETECT, delivering a next-generation slimline device designed for manufacturability, proving early revenue across key segments (including US Medicare, the VA, pharma partners, and Australia’s SAS scheme), and building a go-to-market model aimed at a commercial launch around early 2028.  If you care about epilepsy innovation, digital health, medical device commercialisation, or ASX healthcare stories, subscribe, share this with a mate, and leave a review. What part of objective seizure monitoring do you think will drive adoption first: clinicians, patients, or reimbursement?

  4. Nov 2

    SENSEN NETWORKS LTD (ASX:SNS) - How Councils Use Cameras And Sensors To Automate Street Work

    Send us Fan Mail ASX Investment Opportunity - SenSen Networks Ltd (ASX:SNS) City streets generate endless problems that still get handled the old way: clipboards, call-outs, manual counts, and delayed reporting. We talk with Dr Subhash Challa, CEO of SenSen Networks, about a different approach: physical AI that uses cameras and sensors to automate labour-intensive city council monitoring in real time, turning everyday street activity into data councils can act on quickly. We break down the latest momentum behind the business, including record Q1 cash receipts of $5.3 million and a record annual recurring revenue (ARR) base of about $12 million. Dr Kala explains why council and government customers can be “sticky”, how net revenue retention close to 100% supports compounding growth, and what it takes to stay cash flow positive while still investing for scale. If you care about SaaS fundamentals, this conversation links operating discipline directly to outcomes investors can track. From there, we go deeper into the on-the-ground use cases driving usage growth: curb management and curb enforcement, plus expansion into adjacent smart city applications like noise and high-noise vehicle detection, illegal dumping management, and city asset mapping and digitisation. We also cover why landing EPA Victoria matters for credibility and upsell, how a platform strategy reduces friction for future sales, and what the North American wins in cities like Montreal and Pittsburgh signal for growth. Finally, we look at emerging opportunities including smart city deployments in India, plus local government trials in Victoria and Western Australia, and we ask what “real progress” should look like by the end of FY27, with a focus on increasing the quantum of cash flow alongside sustained top-line growth. Subscribe for more ASX Briefs conversations, share this with someone watching smart city tech, and leave a review with the key metric you think matters most.

  5. Oct 27

    KGL RESOURCES LTD (ASX:KGL) - How KGL Moves Jervois From Plan To Construction

    Send us Fan Mail ASX Investment Opportunity - KGL Resources Ltd (ASX:KGL) A mining project can look great on paper and still fail on the basics: funding, timing, and execution. We sit down with Sam Strohmayr, CEO of KGL Resources, to unpack how the Jervois copper project in the Northern Territory moves past the point of promise and into real construction, with first copper concentrate targeted for early 2028. We talk through the board’s Final Investment Decision and what had to be in place before KGL could confidently say “go”. Sam explains the project’s financing in plain terms, including the precious metals streaming agreement with Wheaton Precious Metals and the subsequent equity raise that leaves Jervois fully funded through construction and into production with no project debt. If you care about copper mining investment, mine development risk, and how developers avoid constant returns to market, this conversation is packed with practical signals to watch. From there, we get specific about delivery: why Sedgman (CIMIC Group) is selected for the processing plant, what’s already changed on site since the baseline economic model, and which long lead items sit on the critical path, especially the grinding mills and the milling circuit. We also dig into the parallel exploration plan, including the integrated 3D inversion targeting, drilling at the Kylie Prospect, and how KGL aims to extend mine life beyond the current plan. If you found this useful, subscribe to ASX Briefs, share the episode with a mate who follows Australian resources, and leave a review so more people can find the show.

  6. Oct 20

    VECTUS BIOSYSTEMS LTD (ASX:VBS) - A Drug That May Reverse Lung Scarring

    Send us Fan Mail ASX Investment Opportunity - Vectus Biosystems Ltd (ASX:VBS) Lung scarring that won’t stop, treatments that mostly slow the slide, and a median survival often measured in years, not decades, is why idiopathic pulmonary fibrosis (IPF) is one of the most urgent targets in respiratory medicine. We’re joined by Dr Tara Speranza, CEO and CTO of Vectus Biosystems, to explain why the company is putting VB0004 forward as its lead program and why the preclinical signals suggesting fibrosis reversal have caught the attention of clinicians and key opinion leaders. We talk through what “idiopathic” really means, how IPF differs from lung fibrosis caused by smoking, asbestos, or other environmental triggers, and why patients and families are still waiting for something that goes beyond slowing progression. Tara also shares the strategic logic behind leading with a rare disease indication, including the potential benefits of an orphan drug pathway and the practical reality that big heart and kidney fibrosis trials can be far more expensive and recruitment-heavy. On the regulatory front, we unpack the FDA pre-IND Type B meeting, what the agency’s engagement can tell you at this stage, and the specific clarity Vectus is seeking on preclinical coverage and CMC (chemistry, manufacturing and controls). We also cover why Cardinal Health Regulatory Services has been appointed as Vectus’ US agent, and how that expertise supports the step-by-step build towards an IND and US clinical trials. Finally, we look beyond the lead asset: a 1,000+ small molecule fibrosis library, how candidates are screened from in vitro assays into gold-standard animal models, and where AI-driven modelling could help pick the next winners faster. If you care about ASX biotech, pulmonary fibrosis treatment innovation, or how drugs actually move through the FDA pathway, this one’s for you. Subscribe, share the episode with a mate, and leave us a review so more people can find the conversation.

  7. Oct 16

    OVERWATCH TECHNOLOGIES LTD (ASX:OWL) - How Overwatch Turns Drones Into Maritime Intelligence

    Send us Fan Mail ASX Investment Opportunity - Overwatch Technologies Ltd (ASX:OWL) Australia and the Indo-Pacific are dealing with a hard truth: our oceans are vast, threats move fast, and traditional maritime surveillance is expensive to scale. We sit down with Oscar Leslie, Managing Director and co-founder of Overwatch Technologies Limited, to dig into how modern maritime domain awareness can be built with autonomous systems, AI-enabled surveillance, and smart sensor networks that spot what matters before a navy has to launch its most costly assets. Oscar explains why Overwatch stays platform agnostic, choosing the best-value drones and uncrewed surface vessels, then fitting them with proprietary sensors to collect electro-optical imagery and radio frequency signals. We walk through the company’s “sense, capture, process, monetise” model, including how vessel fingerprinting and data fusion can identify suspicious behaviour such as ships that disable AIS. There’s also a deep dive into the strategic value of Overwatch’s exclusive regional licence for military-grade RF sensing technology from Europe-based Polis Tech, and how avoiding US ITAR restrictions can open doors for regional government customers. We also get practical about the numbers and the pathway: why early revenue leans on hardware sales, how contract liabilities work until delivery is completed, and what changes when the business shifts to maritime surveillance as a service with stronger margins and multi-year customer stickiness. Oscar closes with milestones to watch over the next 6 to 12 months, from converting early traction into service contracts to laying foundations for longer-term data monetisation, plus why building sovereign Australian capability matters for allied cooperation frameworks like AUKUS and Five Eyes. Subscribe, share this with a mate who follows defence tech, and leave a review, what part of this scaling story do you want us to unpack next?

  8. Oct 15

    PIONEER CREDIT LTD (ASX:PNC) - Ethical Debt Recovery On The ASX

    Send us Fan Mail ASX Investment Opportunity - Pioneer Credit Ltd (ASX:PNC) A 245% jump in statutory profit doesn’t happen by accident, especially in a part of finance most people only hear about when things go wrong. We’re joined by Keith John, Managing Director of Pioneer Credit Limited, to explain how an ASX-listed debt purchaser can grow fast while keeping customer outcomes and compliance front and centre. If you’ve ever wondered how purchased debt portfolios work, why banks sell non-performing loans, and what “ethical recovery” looks like in practice, this chat lays it out clearly. We walk through the key tailwinds behind Pioneer Credit’s FY26 result, from a surprisingly tight competitive field to the real-world behaviour of Australian consumers under interest rate and cost of living pressure. Keith also explains how being aligned with bank vendors (and not competing by writing new loans) can influence deal flow, pricing, and long-term relationships. Along the way, we discuss the scale of the current receivables book, what “under arrangement” really means, and why disciplined collections matter as much as headline NPAT. Then we get practical on capital structure: debt facility repricing, lower funding margins over BBSW, reduced leverage since COVID, and how a stronger balance sheet can support ongoing portfolio investment and a pathway back to dividends. We also touch on the PwC litigation and what to watch in the next 12 months, before closing on the milestones needed to hit FY27 cash collections guidance and the FY29 NPAT target. If you value clear ASX insights, subscribe, share this with a mate, and leave a review. What’s the bigger signal for you here: cheaper funding, portfolio buying pace, or cash collections?

About

Welcome to 'ASX BRIEFS,' the definitive podcast for enthusiasts, investors, and professionals keen on staying ahead of the curve in the Australian Stock Exchange (ASX). Hosted by Andrew Musgrave, 'ASX BRIEFS' delves deep into the heart of Australia's financial markets, bringing you insightful conversations with the minds shaping the future of investing down under. Each episode, join Andrew as he interviews a diverse lineup of fund managers, executives, and industry insiders, offering you a unique blend of expert analysis, strategic insights, and the latest trends affecting the ASX. Whether you're a seasoned investor or just starting out, 'ASX BRIEFS' is your go-to source for comprehensive updates and thought-provoking discussions designed to inform, inspire, and empower your investment journey. Tune in to 'ASX BRIEFS' and take the pulse of Australia's financial markets right at your fingertips.

You Might Also Like